Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Reata Expands Options For Bardoxolone With New CKD Data

Feb 20 2019

• By Joseph Haas

Human kidney on scientific background. 3d illustration

Related Content

Bardoxolone Blow-Up: Reata/Abbott CKD Drug Halted In Phase III

Nov 01 2012

Pay Day For Reata As Bardoxolone Progresses For Kidney Disease In Japan

Aug 31 2018

Outlook For Reata's Bardoxolone Improves With Phase II Updates

Jul 24 2018

Related Companies

Reata Pharmaceuticals, Inc.

Kyowa Kirin Co., Ltd.

AbbVie Inc.

Abbott

Additional Topics

Clinical Trials Research & Development Companies Renal BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window